Atlas Venture Life Science Advisors, LLC Long-Term Concentrated

CIK: 0001917529 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 3, 2022

Total Value ($000): $598,160 (100.0% shares, 0.0% debt)

Holdings (16)

DAWN Day One Biopharmaceuticals, Inc. 26.8%

Value ($000) $160,533 Shares 8,968,305 Est. Cost $19.68 Unrealized -47.5%

KYMR Kymera Therapeutics, Inc. 22.6%

Value ($000) $135,382 Shares 6,875,698 Est. Cost $58.25 Unrealized -59.9%

DYN Dyne Therapeutics, Inc. 10.3%

Value ($000) $61,383 Shares 8,934,902 Est. Cost $14.05 Unrealized -51.0%

REPL Replimune Group, Inc. 9.4%

Value ($000) $56,104 Shares 3,209,627 Est. Cost $29.91 Unrealized -45.1%

— Generation Bio, Co. 9.1%

Value ($000) $54,309 Shares 8,278,876 Est. Cost $7.08 Unrealized —

— Aerovate Therapeutics, Inc. 6.9%

Value ($000) $41,237 Shares 2,638,297 Est. Cost $11.79 Unrealized —

— Ikena Oncology, Inc. 3.7%

Value ($000) $22,231 Shares 5,018,178 Est. Cost $12.54 Unrealized —

— Akero Therapeutics, Inc. 3.5%

Value ($000) $21,095 Shares 2,232,251 Est. Cost $21.15 Unrealized —

— Vigil Neuroscience, Inc. 2.5%

Value ($000) $15,059 Shares 5,836,874 Est. Cost $7.03 Unrealized —

— Gemini Therapeutics, Inc. 1.5%

Value ($000) $8,880 Shares 5,254,365 Est. Cost $2.91 Unrealized —

XLO Xilio Therapeutics, Inc. 1.3%

Value ($000) $8,057 Shares 2,759,344 Est. Cost $17.03 Unrealized -77.8%

— Magenta Therapeutics, Inc. 0.7%

Value ($000) $4,172 Shares 3,476,536 Est. Cost $4.43 Unrealized —

— AvroBio, Inc. 0.7%

Value ($000) $4,159 Shares 4,520,863 Est. Cost $3.85 Unrealized —

— F-star Therapeutics, Inc. 0.6%

Value ($000) $3,753 Shares 599,524 Est. Cost $5.02 Unrealized —

VRDN Viridian Therapeutics, Inc. 0.2%

Value ($000) $1,042 Shares 90,072 Est. Cost $18.63 Unrealized -27.9%

SPRO Spero Therapeutics, Inc. 0.1%

Value ($000) $764 Shares 1,031,160 Est. Cost $15.88 Unrealized -81.7%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
DAWN	Day One Biopharmaceuticals, Inc.	8,968,305	$160,533	26.8%	$19.68	-47.5%	Common Stock	23954D109
KYMR	Kymera Therapeutics, Inc.	6,875,698	$135,382	22.6%	$58.25	-59.9%	Common Stock	501575104
DYN	Dyne Therapeutics, Inc.	8,934,902	$61,383	10.3%	$14.05	-51.0%	Common Stock	26818M108
REPL	Replimune Group, Inc.	3,209,627	$56,104	9.4%	$29.91	-45.1%	Common Stock	76029N106
—	Generation Bio, Co.	8,278,876	$54,309	9.1%	$7.08	—	Common Stock	37148K100
—	Aerovate Therapeutics, Inc.	2,638,297	$41,237	6.9%	$11.79	—	Common Stock	008064107
—	Ikena Oncology, Inc.	5,018,178	$22,231	3.7%	$12.54	—	Common Stock	45175G108
—	Akero Therapeutics, Inc.	2,232,251	$21,095	3.5%	$21.15	—	Common Stock	00973Y108
—	Vigil Neuroscience, Inc.	5,836,874	$15,059	2.5%	$7.03	—	Common Stock	92673K108
—	Gemini Therapeutics, Inc.	5,254,365	$8,880	1.5%	$2.91	—	Common Stock	36870G105
XLO	Xilio Therapeutics, Inc.	2,759,344	$8,057	1.3%	$17.03	-77.8%	Common Stock	98422T100
—	Magenta Therapeutics, Inc.	3,476,536	$4,172	0.7%	$4.43	—	Common Stock	55910K108
—	AvroBio, Inc.	4,520,863	$4,159	0.7%	$3.85	—	Common Stock	05455M100
—	F-star Therapeutics, Inc.	599,524	$3,753	0.6%	$5.02	—	Common Stock	30315R107
VRDN	Viridian Therapeutics, Inc.	90,072	$1,042	0.2%	$18.63	-27.9%	Common Stock	92790C104
SPRO	Spero Therapeutics, Inc.	1,031,160	$764	0.1%	$15.88	-81.7%	Common Stock	84833T103